nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—SCN8A—peripheral nervous system—type 2 diabetes mellitus	0.0194	0.206	CbGeAlD
Mepivacaine—SCN8A—nerve—type 2 diabetes mellitus	0.0151	0.16	CbGeAlD
Mepivacaine—SCN10A—peripheral nervous system—type 2 diabetes mellitus	0.013	0.138	CbGeAlD
Mepivacaine—SCN10A—nerve—type 2 diabetes mellitus	0.0101	0.107	CbGeAlD
Mepivacaine—SCN9A—nephron tubule—type 2 diabetes mellitus	0.00517	0.0549	CbGeAlD
Mepivacaine—SCN9A—adipose tissue—type 2 diabetes mellitus	0.0041	0.0435	CbGeAlD
Mepivacaine—SCN4A—kidney—type 2 diabetes mellitus	0.00406	0.0431	CbGeAlD
Mepivacaine—SCN10A—nephron tubule—type 2 diabetes mellitus	0.00394	0.0418	CbGeAlD
Mepivacaine—SCN4A—adipose tissue—type 2 diabetes mellitus	0.00366	0.0388	CbGeAlD
Mepivacaine—SCN2A—cortex of kidney—type 2 diabetes mellitus	0.0035	0.0371	CbGeAlD
Mepivacaine—SCN5A—cardiovascular system—type 2 diabetes mellitus	0.00322	0.0341	CbGeAlD
Mepivacaine—SCN3A—kidney—type 2 diabetes mellitus	0.00316	0.0335	CbGeAlD
Mepivacaine—SCN3A—cortex of kidney—type 2 diabetes mellitus	0.00307	0.0326	CbGeAlD
Mepivacaine—SCN3A—adipose tissue—type 2 diabetes mellitus	0.00284	0.0302	CbGeAlD
Mepivacaine—Levobupivacaine—CYP1A2—type 2 diabetes mellitus	0.00239	0.151	CrCbGaD
Mepivacaine—Lidocaine—EGFR—type 2 diabetes mellitus	0.00203	0.128	CrCbGaD
Mepivacaine—Bupivacaine—CYP1A2—type 2 diabetes mellitus	0.00191	0.12	CrCbGaD
Mepivacaine—Levobupivacaine—CYP3A4—type 2 diabetes mellitus	0.00158	0.0996	CrCbGaD
Mepivacaine—Ropivacaine—CYP1A2—type 2 diabetes mellitus	0.00154	0.097	CrCbGaD
Mepivacaine—Vision blurred—Glyburide—type 2 diabetes mellitus	0.0015	0.00288	CcSEcCtD
Mepivacaine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.0015	0.00287	CcSEcCtD
Mepivacaine—Tremor—Glyburide—type 2 diabetes mellitus	0.00149	0.00286	CcSEcCtD
Mepivacaine—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.00148	0.00283	CcSEcCtD
Mepivacaine—Chills—Gliclazide—type 2 diabetes mellitus	0.00147	0.00282	CcSEcCtD
Mepivacaine—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00147	0.00282	CcSEcCtD
Mepivacaine—Angioedema—Glyburide—type 2 diabetes mellitus	0.00145	0.00279	CcSEcCtD
Mepivacaine—Nausea—Acarbose—type 2 diabetes mellitus	0.00145	0.00278	CcSEcCtD
Mepivacaine—Tocainide—CYP1A2—type 2 diabetes mellitus	0.00145	0.0912	CrCbGaD
Mepivacaine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00144	0.00277	CcSEcCtD
Mepivacaine—Erythema—Gliclazide—type 2 diabetes mellitus	0.00143	0.00274	CcSEcCtD
Mepivacaine—Oedema—Bromocriptine—type 2 diabetes mellitus	0.00142	0.00272	CcSEcCtD
Mepivacaine—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.00141	0.00271	CcSEcCtD
Mepivacaine—Tension—Gliclazide—type 2 diabetes mellitus	0.0014	0.00269	CcSEcCtD
Mepivacaine—Somnolence—Glimepiride—type 2 diabetes mellitus	0.0014	0.00268	CcSEcCtD
Mepivacaine—Nausea—Nateglinide—type 2 diabetes mellitus	0.0014	0.00268	CcSEcCtD
Mepivacaine—Bradycardia—Metformin—type 2 diabetes mellitus	0.0014	0.00268	CcSEcCtD
Mepivacaine—Shock—Bromocriptine—type 2 diabetes mellitus	0.0014	0.00268	CcSEcCtD
Mepivacaine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00139	0.00268	CcSEcCtD
Mepivacaine—Nervousness—Gliclazide—type 2 diabetes mellitus	0.00139	0.00266	CcSEcCtD
Mepivacaine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00139	0.00266	CcSEcCtD
Mepivacaine—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.00138	0.00265	CcSEcCtD
Mepivacaine—Back pain—Gliclazide—type 2 diabetes mellitus	0.00138	0.00265	CcSEcCtD
Mepivacaine—Convulsion—Glyburide—type 2 diabetes mellitus	0.00138	0.00264	CcSEcCtD
Mepivacaine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00136	0.00262	CcSEcCtD
Mepivacaine—Urticaria—Glipizide—type 2 diabetes mellitus	0.00134	0.00257	CcSEcCtD
Mepivacaine—Tremor—Gliclazide—type 2 diabetes mellitus	0.00134	0.00257	CcSEcCtD
Mepivacaine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00133	0.00255	CcSEcCtD
Mepivacaine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.00132	0.00253	CcSEcCtD
Mepivacaine—Agitation—Gliclazide—type 2 diabetes mellitus	0.00131	0.00252	CcSEcCtD
Mepivacaine—Angioedema—Gliclazide—type 2 diabetes mellitus	0.0013	0.0025	CcSEcCtD
Mepivacaine—Sweating—Losartan—type 2 diabetes mellitus	0.0013	0.0025	CcSEcCtD
Mepivacaine—Oedema—Glyburide—type 2 diabetes mellitus	0.0013	0.00249	CcSEcCtD
Mepivacaine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.0013	0.00249	CcSEcCtD
Mepivacaine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00128	0.00246	CcSEcCtD
Mepivacaine—Headache—Repaglinide—type 2 diabetes mellitus	0.00128	0.00245	CcSEcCtD
Mepivacaine—Shock—Glyburide—type 2 diabetes mellitus	0.00128	0.00245	CcSEcCtD
Mepivacaine—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.00127	0.00245	CcSEcCtD
Mepivacaine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00127	0.00244	CcSEcCtD
Mepivacaine—Sweating increased—Ramipril—type 2 diabetes mellitus	0.00127	0.00244	CcSEcCtD
Mepivacaine—Back pain—Valsartan—type 2 diabetes mellitus	0.00127	0.00244	CcSEcCtD
Mepivacaine—Bupivacaine—CYP3A4—type 2 diabetes mellitus	0.00126	0.0797	CrCbGaD
Mepivacaine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00126	0.00242	CcSEcCtD
Mepivacaine—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.00125	0.00241	CcSEcCtD
Mepivacaine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.00125	0.00241	CcSEcCtD
Mepivacaine—Back pain—Orlistat—type 2 diabetes mellitus	0.00125	0.00241	CcSEcCtD
Mepivacaine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00125	0.0024	CcSEcCtD
Mepivacaine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00125	0.00239	CcSEcCtD
Mepivacaine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00124	0.00238	CcSEcCtD
Mepivacaine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00124	0.00237	CcSEcCtD
Mepivacaine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.00124	0.00237	CcSEcCtD
Mepivacaine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.00123	0.00237	CcSEcCtD
Mepivacaine—Chills—Metformin—type 2 diabetes mellitus	0.00123	0.00236	CcSEcCtD
Mepivacaine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00122	0.00234	CcSEcCtD
Mepivacaine—Hypotension—Glyburide—type 2 diabetes mellitus	0.00121	0.00233	CcSEcCtD
Mepivacaine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.00121	0.00232	CcSEcCtD
Mepivacaine—Nausea—Repaglinide—type 2 diabetes mellitus	0.00121	0.00232	CcSEcCtD
Mepivacaine—Asthenia—Glipizide—type 2 diabetes mellitus	0.00121	0.00232	CcSEcCtD
Mepivacaine—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.00121	0.00232	CcSEcCtD
Mepivacaine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00121	0.00232	CcSEcCtD
Mepivacaine—Angioedema—Valsartan—type 2 diabetes mellitus	0.0012	0.0023	CcSEcCtD
Mepivacaine—Erythema—Metformin—type 2 diabetes mellitus	0.00119	0.00229	CcSEcCtD
Mepivacaine—Pruritus—Glipizide—type 2 diabetes mellitus	0.00119	0.00229	CcSEcCtD
Mepivacaine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00119	0.00228	CcSEcCtD
Mepivacaine—Angioedema—Orlistat—type 2 diabetes mellitus	0.00118	0.00227	CcSEcCtD
Mepivacaine—Syncope—Valsartan—type 2 diabetes mellitus	0.00118	0.00226	CcSEcCtD
Mepivacaine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.00116	0.00224	CcSEcCtD
Mepivacaine—Chills—Irbesartan—type 2 diabetes mellitus	0.00116	0.00223	CcSEcCtD
Mepivacaine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00116	0.00222	CcSEcCtD
Mepivacaine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00116	0.00222	CcSEcCtD
Mepivacaine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00116	0.00222	CcSEcCtD
Mepivacaine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.00115	0.00221	CcSEcCtD
Mepivacaine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00114	0.0022	CcSEcCtD
Mepivacaine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00114	0.00218	CcSEcCtD
Mepivacaine—Tinnitus—Losartan—type 2 diabetes mellitus	0.00114	0.00218	CcSEcCtD
Mepivacaine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00113	0.00217	CcSEcCtD
Mepivacaine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00113	0.00216	CcSEcCtD
Mepivacaine—Erythema—Irbesartan—type 2 diabetes mellitus	0.00113	0.00216	CcSEcCtD
Mepivacaine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00113	0.00216	CcSEcCtD
Mepivacaine—Vision blurred—Metformin—type 2 diabetes mellitus	0.00113	0.00216	CcSEcCtD
Mepivacaine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00113	0.00216	CcSEcCtD
Mepivacaine—Convulsion—Orlistat—type 2 diabetes mellitus	0.00112	0.00216	CcSEcCtD
Mepivacaine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00112	0.00215	CcSEcCtD
Mepivacaine—Tremor—Metformin—type 2 diabetes mellitus	0.00112	0.00215	CcSEcCtD
Mepivacaine—Lidocaine—CYP1A2—type 2 diabetes mellitus	0.00112	0.0705	CrCbGaD
Mepivacaine—Sweating—Ramipril—type 2 diabetes mellitus	0.00112	0.00214	CcSEcCtD
Mepivacaine—Dizziness—Glipizide—type 2 diabetes mellitus	0.00111	0.00214	CcSEcCtD
Mepivacaine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00111	0.00214	CcSEcCtD
Mepivacaine—Anxiety—Valsartan—type 2 diabetes mellitus	0.00111	0.00214	CcSEcCtD
Mepivacaine—Tension—Irbesartan—type 2 diabetes mellitus	0.00111	0.00212	CcSEcCtD
Mepivacaine—Anxiety—Orlistat—type 2 diabetes mellitus	0.0011	0.00211	CcSEcCtD
Mepivacaine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.00109	0.0021	CcSEcCtD
Mepivacaine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00109	0.00209	CcSEcCtD
Mepivacaine—Vomiting—Glipizide—type 2 diabetes mellitus	0.00107	0.00206	CcSEcCtD
Mepivacaine—Syncope—Metformin—type 2 diabetes mellitus	0.00107	0.00206	CcSEcCtD
Mepivacaine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00107	0.00205	CcSEcCtD
Mepivacaine—Oedema—Valsartan—type 2 diabetes mellitus	0.00107	0.00205	CcSEcCtD
Mepivacaine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00107	0.00205	CcSEcCtD
Mepivacaine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00106	0.00204	CcSEcCtD
Mepivacaine—Erythema—Losartan—type 2 diabetes mellitus	0.00106	0.00204	CcSEcCtD
Mepivacaine—Oedema—Orlistat—type 2 diabetes mellitus	0.00106	0.00203	CcSEcCtD
Mepivacaine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00106	0.00203	CcSEcCtD
Mepivacaine—Headache—Glipizide—type 2 diabetes mellitus	0.00106	0.00203	CcSEcCtD
Mepivacaine—Tremor—Irbesartan—type 2 diabetes mellitus	0.00106	0.00203	CcSEcCtD
Mepivacaine—Shock—Valsartan—type 2 diabetes mellitus	0.00105	0.00202	CcSEcCtD
Mepivacaine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.00105	0.00202	CcSEcCtD
Mepivacaine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00105	0.00201	CcSEcCtD
Mepivacaine—Tension—Losartan—type 2 diabetes mellitus	0.00104	0.002	CcSEcCtD
Mepivacaine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00104	0.002	CcSEcCtD
Mepivacaine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00104	0.00199	CcSEcCtD
Mepivacaine—Agitation—Irbesartan—type 2 diabetes mellitus	0.00104	0.00199	CcSEcCtD
Mepivacaine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00104	0.00199	CcSEcCtD
Mepivacaine—Hypertension—Metformin—type 2 diabetes mellitus	0.00103	0.00198	CcSEcCtD
Mepivacaine—Urticaria—Glyburide—type 2 diabetes mellitus	0.00103	0.00198	CcSEcCtD
Mepivacaine—Nervousness—Losartan—type 2 diabetes mellitus	0.00103	0.00198	CcSEcCtD
Mepivacaine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00103	0.00198	CcSEcCtD
Mepivacaine—Back pain—Losartan—type 2 diabetes mellitus	0.00103	0.00197	CcSEcCtD
Mepivacaine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00102	0.00196	CcSEcCtD
Mepivacaine—Ropivacaine—CYP3A4—type 2 diabetes mellitus	0.00102	0.0642	CrCbGaD
Mepivacaine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00102	0.00195	CcSEcCtD
Mepivacaine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00101	0.00194	CcSEcCtD
Mepivacaine—Syncope—Irbesartan—type 2 diabetes mellitus	0.00101	0.00194	CcSEcCtD
Mepivacaine—Nausea—Glipizide—type 2 diabetes mellitus	0.001	0.00192	CcSEcCtD
Mepivacaine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.001	0.00192	CcSEcCtD
Mepivacaine—Hypotension—Valsartan—type 2 diabetes mellitus	0.001	0.00192	CcSEcCtD
Mepivacaine—Vision blurred—Losartan—type 2 diabetes mellitus	0.001	0.00192	CcSEcCtD
Mepivacaine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000997	0.00191	CcSEcCtD
Mepivacaine—Tremor—Losartan—type 2 diabetes mellitus	0.000994	0.00191	CcSEcCtD
Mepivacaine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000991	0.0019	CcSEcCtD
Mepivacaine—Headache—Glimepiride—type 2 diabetes mellitus	0.000985	0.00189	CcSEcCtD
Mepivacaine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000982	0.00189	CcSEcCtD
Mepivacaine—Agitation—Losartan—type 2 diabetes mellitus	0.000975	0.00187	CcSEcCtD
Mepivacaine—Oedema—Metformin—type 2 diabetes mellitus	0.000975	0.00187	CcSEcCtD
Mepivacaine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000974	0.00187	CcSEcCtD
Mepivacaine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000973	0.00187	CcSEcCtD
Mepivacaine—Angioedema—Losartan—type 2 diabetes mellitus	0.000969	0.00186	CcSEcCtD
Mepivacaine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000961	0.00184	CcSEcCtD
Mepivacaine—Shock—Metformin—type 2 diabetes mellitus	0.000959	0.00184	CcSEcCtD
Mepivacaine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000956	0.00184	CcSEcCtD
Mepivacaine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000956	0.00183	CcSEcCtD
Mepivacaine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000951	0.00183	CcSEcCtD
Mepivacaine—Syncope—Losartan—type 2 diabetes mellitus	0.000951	0.00183	CcSEcCtD
Mepivacaine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00095	0.00182	CcSEcCtD
Mepivacaine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000942	0.00181	CcSEcCtD
Mepivacaine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000938	0.0018	CcSEcCtD
Mepivacaine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000934	0.00179	CcSEcCtD
Mepivacaine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000932	0.00179	CcSEcCtD
Mepivacaine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000931	0.00179	CcSEcCtD
Mepivacaine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000931	0.00179	CcSEcCtD
Mepivacaine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000925	0.00178	CcSEcCtD
Mepivacaine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000921	0.00177	CcSEcCtD
Mepivacaine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00092	0.00177	CcSEcCtD
Mepivacaine—Oedema—Irbesartan—type 2 diabetes mellitus	0.00092	0.00177	CcSEcCtD
Mepivacaine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000918	0.00176	CcSEcCtD
Mepivacaine—Hypotension—Metformin—type 2 diabetes mellitus	0.000911	0.00175	CcSEcCtD
Mepivacaine—Erythema—Ramipril—type 2 diabetes mellitus	0.000909	0.00175	CcSEcCtD
Mepivacaine—Shock—Irbesartan—type 2 diabetes mellitus	0.000905	0.00174	CcSEcCtD
Mepivacaine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000902	0.00173	CcSEcCtD
Mepivacaine—Anxiety—Losartan—type 2 diabetes mellitus	0.0009	0.00173	CcSEcCtD
Mepivacaine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000898	0.00172	CcSEcCtD
Mepivacaine—Tension—Ramipril—type 2 diabetes mellitus	0.000892	0.00171	CcSEcCtD
Mepivacaine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000889	0.00171	CcSEcCtD
Mepivacaine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000889	0.00171	CcSEcCtD
Mepivacaine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000883	0.0017	CcSEcCtD
Mepivacaine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000875	0.00168	CcSEcCtD
Mepivacaine—Somnolence—Metformin—type 2 diabetes mellitus	0.000866	0.00166	CcSEcCtD
Mepivacaine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000866	0.00166	CcSEcCtD
Mepivacaine—Oedema—Losartan—type 2 diabetes mellitus	0.000866	0.00166	CcSEcCtD
Mepivacaine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000859	0.00165	CcSEcCtD
Mepivacaine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000858	0.00165	CcSEcCtD
Mepivacaine—Tremor—Ramipril—type 2 diabetes mellitus	0.000852	0.00164	CcSEcCtD
Mepivacaine—Shock—Losartan—type 2 diabetes mellitus	0.000852	0.00163	CcSEcCtD
Mepivacaine—Urticaria—Valsartan—type 2 diabetes mellitus	0.00085	0.00163	CcSEcCtD
Mepivacaine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000845	0.00162	CcSEcCtD
Mepivacaine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000843	0.00162	CcSEcCtD
Mepivacaine—Urticaria—Orlistat—type 2 diabetes mellitus	0.00084	0.00161	CcSEcCtD
Mepivacaine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000837	0.00161	CcSEcCtD
Mepivacaine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000836	0.0016	CcSEcCtD
Mepivacaine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000836	0.0016	CcSEcCtD
Mepivacaine—Agitation—Ramipril—type 2 diabetes mellitus	0.000836	0.0016	CcSEcCtD
Mepivacaine—Tocainide—ALB—type 2 diabetes mellitus	0.000836	0.0527	CrCbGaD
Mepivacaine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000831	0.0016	CcSEcCtD
Mepivacaine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000826	0.00159	CcSEcCtD
Mepivacaine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000825	0.00158	CcSEcCtD
Mepivacaine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000824	0.00158	CcSEcCtD
Mepivacaine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000818	0.00157	CcSEcCtD
Mepivacaine—Syncope—Ramipril—type 2 diabetes mellitus	0.000816	0.00157	CcSEcCtD
Mepivacaine—Headache—Glyburide—type 2 diabetes mellitus	0.000813	0.00156	CcSEcCtD
Mepivacaine—Hypotension—Losartan—type 2 diabetes mellitus	0.000809	0.00155	CcSEcCtD
Mepivacaine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000799	0.00153	CcSEcCtD
Mepivacaine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000789	0.00151	CcSEcCtD
Mepivacaine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000788	0.00151	CcSEcCtD
Mepivacaine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000779	0.0015	CcSEcCtD
Mepivacaine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000777	0.00149	CcSEcCtD
Mepivacaine—Urticaria—Metformin—type 2 diabetes mellitus	0.000774	0.00149	CcSEcCtD
Mepivacaine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000772	0.00148	CcSEcCtD
Mepivacaine—Nausea—Glyburide—type 2 diabetes mellitus	0.000771	0.00148	CcSEcCtD
Mepivacaine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00077	0.00148	CcSEcCtD
Mepivacaine—Somnolence—Losartan—type 2 diabetes mellitus	0.00077	0.00148	CcSEcCtD
Mepivacaine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000768	0.00147	CcSEcCtD
Mepivacaine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000759	0.00146	CcSEcCtD
Mepivacaine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000757	0.00145	CcSEcCtD
Mepivacaine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000748	0.00144	CcSEcCtD
Mepivacaine—Oedema—Ramipril—type 2 diabetes mellitus	0.000742	0.00142	CcSEcCtD
Mepivacaine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000742	0.00142	CcSEcCtD
Mepivacaine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000741	0.00142	CcSEcCtD
Mepivacaine—Lidocaine—CYP3A4—type 2 diabetes mellitus	0.00074	0.0467	CrCbGaD
Mepivacaine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000731	0.0014	CcSEcCtD
Mepivacaine—Shock—Ramipril—type 2 diabetes mellitus	0.00073	0.0014	CcSEcCtD
Mepivacaine—Headache—Gliclazide—type 2 diabetes mellitus	0.00073	0.0014	CcSEcCtD
Mepivacaine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000727	0.0014	CcSEcCtD
Mepivacaine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000724	0.00139	CcSEcCtD
Mepivacaine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000718	0.00138	CcSEcCtD
Mepivacaine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000708	0.00136	CcSEcCtD
Mepivacaine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000699	0.00134	CcSEcCtD
Mepivacaine—Asthenia—Metformin—type 2 diabetes mellitus	0.000699	0.00134	CcSEcCtD
Mepivacaine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000694	0.00133	CcSEcCtD
Mepivacaine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000692	0.00133	CcSEcCtD
Mepivacaine—Pruritus—Metformin—type 2 diabetes mellitus	0.00069	0.00132	CcSEcCtD
Mepivacaine—Urticaria—Losartan—type 2 diabetes mellitus	0.000688	0.00132	CcSEcCtD
Mepivacaine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000684	0.00131	CcSEcCtD
Mepivacaine—Vomiting—Valsartan—type 2 diabetes mellitus	0.00068	0.00131	CcSEcCtD
Mepivacaine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000678	0.0013	CcSEcCtD
Mepivacaine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000672	0.00129	CcSEcCtD
Mepivacaine—Headache—Valsartan—type 2 diabetes mellitus	0.00067	0.00129	CcSEcCtD
Mepivacaine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000666	0.00128	CcSEcCtD
Mepivacaine—Headache—Orlistat—type 2 diabetes mellitus	0.000663	0.00127	CcSEcCtD
Mepivacaine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00066	0.00127	CcSEcCtD
Mepivacaine—Somnolence—Ramipril—type 2 diabetes mellitus	0.00066	0.00127	CcSEcCtD
Mepivacaine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000651	0.00125	CcSEcCtD
Mepivacaine—Dizziness—Metformin—type 2 diabetes mellitus	0.000645	0.00124	CcSEcCtD
Mepivacaine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000638	0.00122	CcSEcCtD
Mepivacaine—Nausea—Valsartan—type 2 diabetes mellitus	0.000636	0.00122	CcSEcCtD
Mepivacaine—Nausea—Orlistat—type 2 diabetes mellitus	0.000628	0.00121	CcSEcCtD
Mepivacaine—Asthenia—Losartan—type 2 diabetes mellitus	0.000621	0.00119	CcSEcCtD
Mepivacaine—Vomiting—Metformin—type 2 diabetes mellitus	0.00062	0.00119	CcSEcCtD
Mepivacaine—Pruritus—Losartan—type 2 diabetes mellitus	0.000612	0.00118	CcSEcCtD
Mepivacaine—Headache—Metformin—type 2 diabetes mellitus	0.000611	0.00117	CcSEcCtD
Mepivacaine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000608	0.00117	CcSEcCtD
Mepivacaine—Urticaria—Ramipril—type 2 diabetes mellitus	0.00059	0.00113	CcSEcCtD
Mepivacaine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000587	0.00113	CcSEcCtD
Mepivacaine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000585	0.00112	CcSEcCtD
Mepivacaine—Nausea—Metformin—type 2 diabetes mellitus	0.000579	0.00111	CcSEcCtD
Mepivacaine—Headache—Irbesartan—type 2 diabetes mellitus	0.000576	0.00111	CcSEcCtD
Mepivacaine—Dizziness—Losartan—type 2 diabetes mellitus	0.000572	0.0011	CcSEcCtD
Mepivacaine—Vomiting—Losartan—type 2 diabetes mellitus	0.00055	0.00106	CcSEcCtD
Mepivacaine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000547	0.00105	CcSEcCtD
Mepivacaine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000546	0.00105	CcSEcCtD
Mepivacaine—Headache—Losartan—type 2 diabetes mellitus	0.000542	0.00104	CcSEcCtD
Mepivacaine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000533	0.00102	CcSEcCtD
Mepivacaine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000525	0.00101	CcSEcCtD
Mepivacaine—Nausea—Losartan—type 2 diabetes mellitus	0.000514	0.000987	CcSEcCtD
Mepivacaine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000491	0.000942	CcSEcCtD
Mepivacaine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000472	0.000906	CcSEcCtD
Mepivacaine—Headache—Ramipril—type 2 diabetes mellitus	0.000465	0.000893	CcSEcCtD
Mepivacaine—Nausea—Ramipril—type 2 diabetes mellitus	0.000441	0.000846	CcSEcCtD
Mepivacaine—SCN10A—Developmental Biology—SLC2A2—type 2 diabetes mellitus	0.000369	0.001	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SLC2A2—type 2 diabetes mellitus	0.000369	0.001	CbGpPWpGaD
Mepivacaine—SCN9A—L1CAM interactions—EGFR—type 2 diabetes mellitus	0.000366	0.000992	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—GCK—type 2 diabetes mellitus	0.000365	0.00099	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—GCK—type 2 diabetes mellitus	0.000365	0.00099	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IAPP—type 2 diabetes mellitus	0.000363	0.000984	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IAPP—type 2 diabetes mellitus	0.000363	0.000984	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—HNF4A—type 2 diabetes mellitus	0.000361	0.000979	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—HNF4A—type 2 diabetes mellitus	0.000361	0.000979	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000358	0.000971	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000356	0.000966	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TRPC6—type 2 diabetes mellitus	0.000354	0.00096	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TRPC6—type 2 diabetes mellitus	0.000354	0.00096	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—PAX6—type 2 diabetes mellitus	0.000353	0.000957	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—GCK—type 2 diabetes mellitus	0.000352	0.000954	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—GCK—type 2 diabetes mellitus	0.000352	0.000954	CbGpPWpGaD
Mepivacaine—SCN3A—L1CAM interactions—EGFR—type 2 diabetes mellitus	0.00035	0.000949	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IAPP—type 2 diabetes mellitus	0.00035	0.000948	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IAPP—type 2 diabetes mellitus	0.00035	0.000948	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PCK1—type 2 diabetes mellitus	0.000345	0.000934	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TRPC6—type 2 diabetes mellitus	0.000342	0.000926	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TRPC6—type 2 diabetes mellitus	0.000342	0.000926	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000341	0.000924	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PAX6—type 2 diabetes mellitus	0.000339	0.000919	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PAX6—type 2 diabetes mellitus	0.000339	0.000919	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—TRPC6—type 2 diabetes mellitus	0.000337	0.000912	CbGpPWpGaD
Mepivacaine—SCN2A—L1CAM interactions—EGFR—type 2 diabetes mellitus	0.000336	0.000912	CbGpPWpGaD
Mepivacaine—SCN4A—L1CAM interactions—EGFR—type 2 diabetes mellitus	0.000336	0.000912	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HNF1B—type 2 diabetes mellitus	0.000335	0.000908	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000329	0.000893	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000328	0.000888	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000328	0.000888	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000327	0.000887	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PAX6—type 2 diabetes mellitus	0.000327	0.000886	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PAX6—type 2 diabetes mellitus	0.000327	0.000886	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000326	0.000884	CbGpPWpGaD
Mepivacaine—SCN1A—L1CAM interactions—EGFR—type 2 diabetes mellitus	0.000324	0.000879	CbGpPWpGaD
Mepivacaine—SCN10A—L1CAM interactions—EGFR—type 2 diabetes mellitus	0.000324	0.000879	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000316	0.000856	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000316	0.000856	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000313	0.000848	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000309	0.000838	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000301	0.000815	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000301	0.000815	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—LPL—type 2 diabetes mellitus	0.0003	0.000813	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000296	0.000801	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.00029	0.000786	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.00029	0.000786	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000285	0.000772	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000284	0.00077	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000284	0.00077	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000274	0.000742	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000274	0.000742	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000266	0.000722	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000265	0.000718	CbGpPWpGaD
Mepivacaine—SCN5A—L1CAM interactions—SRC—type 2 diabetes mellitus	0.00026	0.000705	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SLC2A2—type 2 diabetes mellitus	0.000259	0.000703	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000255	0.00069	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HNF4A—type 2 diabetes mellitus	0.000254	0.000688	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000251	0.000681	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—GCK—type 2 diabetes mellitus	0.000248	0.000671	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IAPP—type 2 diabetes mellitus	0.000246	0.000667	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000245	0.000663	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000245	0.000663	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000243	0.000657	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TRPC6—type 2 diabetes mellitus	0.00024	0.000651	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000236	0.00064	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000236	0.00064	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000232	0.000629	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CD36—type 2 diabetes mellitus	0.00023	0.000624	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PAX6—type 2 diabetes mellitus	0.00023	0.000623	CbGpPWpGaD
Mepivacaine—SCN5A—L1CAM interactions—EGFR—type 2 diabetes mellitus	0.000228	0.000618	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000223	0.000604	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000223	0.000604	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000222	0.000602	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CD36—type 2 diabetes mellitus	0.00022	0.000597	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000219	0.000593	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000215	0.000582	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000215	0.000582	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—INS—type 2 diabetes mellitus	0.000215	0.000582	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000214	0.000581	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000212	0.000574	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000212	0.000574	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000212	0.000574	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000208	0.000562	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000205	0.000555	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000204	0.000553	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000204	0.000553	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000204	0.000553	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000203	0.000551	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000203	0.000549	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000197	0.000533	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000197	0.000533	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—SRC—type 2 diabetes mellitus	0.000195	0.000529	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000194	0.000527	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000193	0.000522	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.00019	0.000515	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.00019	0.000514	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.00019	0.000514	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000189	0.000513	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000187	0.000506	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000187	0.000506	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—LEP—type 2 diabetes mellitus	0.00018	0.000488	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—LEP—type 2 diabetes mellitus	0.00018	0.000488	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000177	0.00048	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000177	0.00048	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—INS—type 2 diabetes mellitus	0.000174	0.000471	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000172	0.000466	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000171	0.000464	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—EGFR—type 2 diabetes mellitus	0.000171	0.000464	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000169	0.000459	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000168	0.000455	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—INS—type 2 diabetes mellitus	0.000166	0.00045	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000166	0.00045	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000164	0.000444	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000163	0.000441	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000163	0.000441	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000161	0.000435	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—INS—type 2 diabetes mellitus	0.00016	0.000432	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—INS—type 2 diabetes mellitus	0.00016	0.000432	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—SRC—type 2 diabetes mellitus	0.000158	0.000428	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000157	0.000426	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000157	0.000426	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000157	0.000425	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000157	0.000425	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000154	0.000418	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000154	0.000418	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—INS—type 2 diabetes mellitus	0.000154	0.000417	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—INS—type 2 diabetes mellitus	0.000154	0.000417	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.000154	0.000417	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000152	0.000411	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000152	0.000411	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000151	0.000409	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000151	0.000409	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—SRC—type 2 diabetes mellitus	0.000151	0.000409	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.000149	0.000405	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000149	0.000403	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000149	0.000403	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000147	0.000399	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.000147	0.000399	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—SRC—type 2 diabetes mellitus	0.000145	0.000393	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—SRC—type 2 diabetes mellitus	0.000145	0.000393	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000144	0.000389	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000143	0.000388	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.000141	0.000383	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.000141	0.000383	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—SRC—type 2 diabetes mellitus	0.00014	0.000379	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—SRC—type 2 diabetes mellitus	0.00014	0.000379	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—SRC—type 2 diabetes mellitus	0.000139	0.000377	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—EGFR—type 2 diabetes mellitus	0.000138	0.000375	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000137	0.000372	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.000136	0.000369	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.000136	0.000369	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—VEGFA—type 2 diabetes mellitus	0.000136	0.000368	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000133	0.000362	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—EGFR—type 2 diabetes mellitus	0.000132	0.000359	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000132	0.000357	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000132	0.000357	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—IL6—type 2 diabetes mellitus	0.000131	0.000356	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—EGFR—type 2 diabetes mellitus	0.000127	0.000345	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—EGFR—type 2 diabetes mellitus	0.000127	0.000345	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000127	0.000344	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000127	0.000344	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000127	0.000343	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TGFB1—type 2 diabetes mellitus	0.000125	0.000337	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—EGFR—type 2 diabetes mellitus	0.000123	0.000332	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—EGFR—type 2 diabetes mellitus	0.000123	0.000332	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000122	0.000331	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—EGFR—type 2 diabetes mellitus	0.000122	0.000331	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.000121	0.000328	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	0.000119	0.000322	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000117	0.000317	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TNF—type 2 diabetes mellitus	0.000116	0.000315	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.000116	0.000313	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—SRC—type 2 diabetes mellitus	0.000113	0.000305	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000112	0.000304	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000112	0.000304	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.000111	0.000301	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.000111	0.000301	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.00011	0.000299	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—VEGFA—type 2 diabetes mellitus	0.00011	0.000297	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000108	0.000293	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000108	0.000293	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—INS—type 2 diabetes mellitus	0.000108	0.000293	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SRC—type 2 diabetes mellitus	0.000108	0.000292	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.000107	0.00029	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.000107	0.00029	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000107	0.000289	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—IL6—type 2 diabetes mellitus	0.000106	0.000288	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—VEGFA—type 2 diabetes mellitus	0.000105	0.000284	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000105	0.000283	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SRC—type 2 diabetes mellitus	0.000104	0.000281	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SRC—type 2 diabetes mellitus	0.000104	0.000281	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—IL6—type 2 diabetes mellitus	0.000102	0.000276	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—VEGFA—type 2 diabetes mellitus	0.000101	0.000273	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—VEGFA—type 2 diabetes mellitus	0.000101	0.000273	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TGFB1—type 2 diabetes mellitus	0.000101	0.000273	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SRC—type 2 diabetes mellitus	9.98e-05	0.000271	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SRC—type 2 diabetes mellitus	9.98e-05	0.000271	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—EGFR—type 2 diabetes mellitus	9.87e-05	0.000268	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—SRC—type 2 diabetes mellitus	9.83e-05	0.000267	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—IL6—type 2 diabetes mellitus	9.77e-05	0.000265	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—IL6—type 2 diabetes mellitus	9.77e-05	0.000265	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—VEGFA—type 2 diabetes mellitus	9.72e-05	0.000263	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—VEGFA—type 2 diabetes mellitus	9.72e-05	0.000263	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TGFB1—type 2 diabetes mellitus	9.63e-05	0.000261	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—VEGFA—type 2 diabetes mellitus	9.58e-05	0.00026	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—EGFR—type 2 diabetes mellitus	9.44e-05	0.000256	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—IL6—type 2 diabetes mellitus	9.42e-05	0.000255	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—IL6—type 2 diabetes mellitus	9.42e-05	0.000255	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TNF—type 2 diabetes mellitus	9.4e-05	0.000255	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—IL6—type 2 diabetes mellitus	9.38e-05	0.000254	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TGFB1—type 2 diabetes mellitus	9.25e-05	0.000251	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TGFB1—type 2 diabetes mellitus	9.25e-05	0.000251	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—EGFR—type 2 diabetes mellitus	9.07e-05	0.000246	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—EGFR—type 2 diabetes mellitus	9.07e-05	0.000246	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TNF—type 2 diabetes mellitus	8.99e-05	0.000244	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—RELA—type 2 diabetes mellitus	8.93e-05	0.000242	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TGFB1—type 2 diabetes mellitus	8.92e-05	0.000242	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TGFB1—type 2 diabetes mellitus	8.92e-05	0.000242	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—EGFR—type 2 diabetes mellitus	8.75e-05	0.000237	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—EGFR—type 2 diabetes mellitus	8.75e-05	0.000237	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—AKT1—type 2 diabetes mellitus	8.66e-05	0.000235	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TNF—type 2 diabetes mellitus	8.64e-05	0.000234	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TNF—type 2 diabetes mellitus	8.64e-05	0.000234	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—EGFR—type 2 diabetes mellitus	8.62e-05	0.000234	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TNF—type 2 diabetes mellitus	8.33e-05	0.000226	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TNF—type 2 diabetes mellitus	8.33e-05	0.000226	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MMP9—type 2 diabetes mellitus	7.61e-05	0.000206	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—IL6—type 2 diabetes mellitus	7.59e-05	0.000206	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NFKB1—type 2 diabetes mellitus	7.53e-05	0.000204	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—IL6—type 2 diabetes mellitus	7.26e-05	0.000197	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SRC—type 2 diabetes mellitus	7.02e-05	0.00019	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—AKT1—type 2 diabetes mellitus	7e-05	0.00019	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IL6—type 2 diabetes mellitus	6.97e-05	0.000189	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IL6—type 2 diabetes mellitus	6.97e-05	0.000189	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—VEGFA—type 2 diabetes mellitus	6.84e-05	0.000185	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IL6—type 2 diabetes mellitus	6.72e-05	0.000182	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IL6—type 2 diabetes mellitus	6.72e-05	0.000182	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—AKT1—type 2 diabetes mellitus	6.7e-05	0.000181	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—IL6—type 2 diabetes mellitus	6.62e-05	0.00018	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—AKT1—type 2 diabetes mellitus	6.43e-05	0.000174	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—AKT1—type 2 diabetes mellitus	6.43e-05	0.000174	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TGFB1—type 2 diabetes mellitus	6.27e-05	0.00017	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—AKT1—type 2 diabetes mellitus	6.2e-05	0.000168	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—AKT1—type 2 diabetes mellitus	6.2e-05	0.000168	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—EGFR—type 2 diabetes mellitus	6.15e-05	0.000167	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TNF—type 2 diabetes mellitus	5.86e-05	0.000159	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IL6—type 2 diabetes mellitus	4.73e-05	0.000128	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—AKT1—type 2 diabetes mellitus	4.36e-05	0.000118	CbGpPWpGaD
